Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Astrum Therapeutics Pty Ltd

Astrum Therapeutics Pty Ltd Patent applications
Patent application numberTitlePublished
20090169648COMPOSITIONS TO REDUCE BLOOD GLUCOSE LEVELS AND TREAT DIABETES - The invention discloses compositions that effectively reduce and stabilize glucose levels in the blood of mammals, specifically in pre-diabetic patients and patients with type 2 diabetes mellitus (T2DM). Composition 1 (Comp1) reinforces efficacy of Mg salt to reduce glucose level by the combination of Mg salt with anti-inflammatory agents konjac-glucomannan (KGM), vitamin C and alpha-lipoic acid (α-LA). Composition 2 (Comp2) provides safety for chromium picolinate (CrPic) by the combination of CrPic with anti-inflammatory agents KGM, vitamin C and α-LA that inhibits oxygen radicals. Compositions may optionally include cinnamon extract (CE) or another insulinogenic nutraceutical agent, American ginseng (AG), 07-02-2009
20080255091COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS - The invention discloses aromatic amides and sulfonates to treat or prevent type 2 diabetes mellitus (T2DM), the pathological consequences of T2DM, to inhibit amyloidosis or to prevent death of β-cells of the pancreas.10-16-2008

Patent applications by Astrum Therapeutics Pty Ltd